98%
921
2 minutes
20
Background: Primary graft dysfunction (PGD) is a major cause of early mortality following heart transplant (HT). The International Society for Heart and Lung Transplantation (ISHLT) subdivides PGD into 3 grades of increasing severity. Most studies have assessed risk factors for PGD without distinguishing between PGD severity grade. We sought to identify recipient, donor and surgical risk factors specifically associated with mild/moderate or severe PGD.
Methods: We identified 734 heart transplant recipients at our institution transplanted between January 1, 2012 and December 31, 2018. PGD was defined according to modified ISHLT criteria. Recipient, donor and surgical variables were analyzed by multinomial logistic regression with mild/moderate or severe PGD as the response. Variables significant in single variable modeling were subject to multivariable analysis via penalized logistic regression.
Results: PGD occurred in 24% of the cohort (n = 178) of whom 6% (n = 44) had severe PGD. One-year survival was reduced in recipients with severe PGD but not in those with mild or moderate PGD. Multivariable analysis identified 3 recipient factors: prior cardiac surgery, recipient treatment with ACEI/ARB/ARNI plus MRA, recipient treatment with amiodarone plus beta-blocker, and 3 surgical factors: longer ischemic time, more red blood cell transfusions, and more platelet transfusions, that were associated with severe PGD. We developed a clinical risk score, ABCE, which provided acceptable discrimination and calibration for severe PGD.
Conclusions: Risk factors for mild/moderate PGD were largely distinct from those for severe PGD, suggesting a differing pathophysiology involving several biological pathways. Further research into mechanisms underlying the development of PGD is urgently needed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.healun.2021.06.002 | DOI Listing |
Immun Inflamm Dis
September 2025
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA.
Background: Uncertainties persist regarding the utilization of hearts from SARS-CoV-2-positive donors for heart transplant (HT). This international study analyzed such HTs within the United States (US) and Germany, focusing on 1-year outcomes and granular safety data.
Methods: Data was obtained from the United Network for Organ Sharing (UNOS) registry (03/2021-08/2022) and collaborating with the German Organ Procurement Organisation (DSO; 03/2022-02/2023).
Clin Transplant
September 2025
Cedars-Sinai Smidt Heart Institute, Los Angeles, California, USA.
Background: Severe left ventricular/biventricular primary graft dysfunction (PGD-LV) continues to be a major contributor to 30-day mortality post-heart transplantation (HTx). In patients with severe PGD-LV, two distinctive presentation phenotypes are encountered: an "immediate PGD" (IP), where patients fail to wean from cardiopulmonary bypass (CPB), or a "delayed PGD" (DP) following successful weaning from CPB and/or transfer from the operating room. Data on these phenotypes' incidence, associated characteristics, and outcomes remain limited.
View Article and Find Full Text PDFJ Obstet Gynaecol India
August 2025
Nowrosjee Wadia Hospital, Mumbai, India.
Fetal anomalies-also known as congenital anomalies or birth defects-are unusual conditions that affect fetus during pregnancy. It can affect one or multiple organs, can be structural or functional and range from mild, moderate to severe. Fetal anomalies are present in 3-5% of live births.
View Article and Find Full Text PDFJ Heart Lung Transplant
August 2025
Department of Surgery, Division of Cardiac Surgery, University of California, Los Angeles, California. Electronic address:
Background: This study aims to assess predictors and outcomes of severe primary graft dysfunction (PGD) in a contemporary United States cohort.
Methods: The United Network for Organ Sharing database was retrospectively reviewed for isolated adult heart transplant recipients (September 2023-March 2025). The population was stratified into severe PGD (left or biventricular dysfunction within 24 hours following transplantation that requires mechanical circulatory support [MCS]) and control cohorts (all other recipients).
J Thorac Cardiovasc Surg
August 2025
Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center.
Objective: The United States experience with heart transplantation following donation after circulatory death (DCD HT) has expanded since clinical adoption in 2019. We aimed to examine a large institution's outcomes associated with DCD HT vs HT following donation after brain death (DBD).
Methods: Adult heart recipients and corresponding donors at a single quaternary academic center from January 2019 to October 2024 were included.